These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23220021)

  • 21. Discovery of differentially expressed genes related to histological subtype of hepatocellular carcinoma.
    Lee D; Choi SW; Kim M; Park JH; Kim M; Kim J; Lee IB
    Biotechnol Prog; 2003; 19(3):1011-5. PubMed ID: 12790669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma.
    Chen MH; Yang WL; Lin KT; Liu CH; Liu YW; Huang KW; Chang PM; Lai JM; Hsu CN; Chao KM; Kao CY; Huang CY
    PLoS One; 2011; 6(11):e27186. PubMed ID: 22087264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas.
    Chuu JJ; Liu JM; Tsou MH; Huang CL; Chen CP; Wang HS; Chen CT
    J Biomed Sci; 2007 Mar; 14(2):233-44. PubMed ID: 17206490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early molecular and genetic determinants of primary liver malignancy.
    Feitelson MA; Pan J; Lian Z
    Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
    Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
    Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer.
    Lee JS; Thorgeirsson SS
    Hepatology; 2002 May; 35(5):1134-43. PubMed ID: 11981763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection].
    Huang XY; Huang ZL; Tang ZY; Xu B; Zheng Q; Zhou J; Wang L; Ye SL
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1278-82. PubMed ID: 20646604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
    Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL
    Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic profiling of human hepatocellular carcinoma.
    Lee JS; Thorgeirsson SS
    Semin Liver Dis; 2005; 25(2):125-32. PubMed ID: 15918141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
    Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
    Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
    Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.
    Berger E; Vega N; Vidal H; Geloën A
    Biotechnol J; 2012 Nov; 7(11):1395-404. PubMed ID: 22930530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
    Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
    J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma.
    van Malenstein H; Gevaert O; Libbrecht L; Daemen A; Allemeersch J; Nevens F; Van Cutsem E; Cassiman D; De Moor B; Verslype C; van Pelt J
    Clin Cancer Res; 2010 Aug; 16(16):4278-88. PubMed ID: 20592013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational Analysis of Transcriptomic and Proteomic Data for Deciphering Molecular Heterogeneity and Drug Responsiveness in Model Human Hepatocellular Carcinoma Cell Lines.
    Agioutantis PC; Loutrari H; Kolisis FN
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32517019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
    Schulze K; Imbeaud S; Letouzé E; Alexandrov LB; Calderaro J; Rebouissou S; Couchy G; Meiller C; Shinde J; Soysouvanh F; Calatayud AL; Pinyol R; Pelletier L; Balabaud C; Laurent A; Blanc JF; Mazzaferro V; Calvo F; Villanueva A; Nault JC; Bioulac-Sage P; Stratton MR; Llovet JM; Zucman-Rossi J
    Nat Genet; 2015 May; 47(5):505-511. PubMed ID: 25822088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways.
    Yu L; Wang M; Yang Y; Xu F; Zhang X; Xie F; Gao L; Li X
    PLoS Comput Biol; 2021 Feb; 17(2):e1008696. PubMed ID: 33561121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.